Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/43087
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorSánchez Caraballo, Jorge Mario-
dc.contributor.authorMúnera Gómez, Marlon Gustavo-
dc.contributor.authorArango Rincón, Julián Camilo-
dc.contributor.authorCardona Villa, Ricardo-
dc.contributor.authorPuerta, Leonardo-
dc.date.accessioned2024-11-03T13:57:19Z-
dc.date.available2024-11-03T13:57:19Z-
dc.date.issued2020-
dc.identifier.citationSánchez, Jorge & Munera, Marlon & Arango, Julian & Cardona, Ricardo & Puerta, Leonardo. (2020). IgE auto-antibodies to human fatty acid-binding proteins in atopic dermatitis patients. Current Trends in Immunology. 21. 29-39.spa
dc.identifier.issn0972-4567-
dc.identifier.urihttps://hdl.handle.net/10495/43087-
dc.description.abstractABSTRACT: IgE auto-antibodies have been described in some allergic diseases, especially in atopic dermatitis (AD). Clinical implications of these antibodies in allergies are not fully understood, but IgE sensitization to self-proteins may represent an important mechanism involved in the maintenance of severe chronic forms. The aim of this study was to explore the presence of the auto reactive IgE response to endogenous fatty acid-binding proteins (FABPs) from the heart (FABP3) and adipocytes (FABP4), two proteins homologous to group 13 of house dust mite (HDM) allergens, in patients with AD. Seventy-one patients with AD and sixty individuals without AD were recruited. After complete clinical evaluation and informed consent, skin prick test (SPT) and serum IgE, IgG and IgG4 levels were determined using extracts of Dermatophagoides pteronyssinus and Blomia tropicalis, the recombinants FABP3 and FABP4, and the allergen Blo t 13. The frequency of positive IgE levels to FABP3 and FABP4 in AD group was 61 and 52%, respectively. Patients with positive IgE auto-reactivity to human FABPs were also sensitized to Blo t 13. IgG and IgG4 levels to FABP3 and FABP4 were detected in all AD patients and no-AD subjects, with the antibody levels in no-AD subjects being significantly higher than those in AD patients. In conclusion, patients with AD, who had positive SPT and serum IgE levels to Blo t 13 allergen showed serum IgE and IgG antibodies against FABP3 and FABP4. The molecular mimicry with HDM allergens could explain this finding, which could contribute to the pathomechanism of AD.spa
dc.format.extent11 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherResearch Trendsspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleIgE auto-antibodies to human fatty acid-binding proteins in atopic dermatitis patientsspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupCentro de de Investigaciones Dermatológicasspa
dc.publisher.groupGrupo de Alergología Clínica y Experimental (GACE)spa
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
oaire.citationtitleCurrent Trends in Immunologyspa
oaire.citationstartpage29spa
oaire.citationendpage39spa
oaire.citationvolume21spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
oaire.fundernameUniversidad de Antioquia. Vicerrectoría de investigación. Comité para el Desarrollo de la Investigación - CODIspa
oaire.fundernameColombia. Ministerio de Ciencia, Tecnología e Innovación - MinCienciasspa
oaire.fundernameUniversidad de Cartagenaspa
dc.publisher.placeTrivandrum, Indiaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsDermatitis-
dc.subject.decsEccema-
dc.subject.decsEczema-
dc.subject.decsProteína 3 de Unión a Ácidos Grasos-
dc.subject.decsFatty Acid Binding Protein 3-
dc.subject.decsPyroglyphidae-
dc.subject.decsDermatitis Atópica-
dc.subject.decsDermatitis, Atopic-
dc.subject.decsInmunoglobulina E-
dc.subject.decsImmunoglobulin E-
dc.subject.decsAutoanticuerpos-
dc.subject.decsAutoantibodies-
dc.description.researchgroupidCOL0130733spa
dc.description.researchgroupidCOL0059567spa
oaire.awardnumberGrant 368-2011spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D003872-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D004485-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D000074026-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D039981-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D003876-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D007073-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D001323-
dc.relation.ispartofjournalabbrevCurr. Trends. Immunol.spa
oaire.funderidentifier.rorRoR:03bp5hc83-
oaire.funderidentifier.rorRoR:03fd5ne08-
oaire.funderidentifier.rorRoR:0409zd934-
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
SanchezJorge_2020_IgE_Auto-antibodies_Human.pdfArtículo de investigación195.72 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons